Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3C.L Regulatory News (K3C)

  • There is currently no data for K3C

Investor Presentation

19 Oct 2021 07:00

RNS Number : 4115P
K3 Capital Group PLC
19 October 2021
 

 

 

K3 CAPITAL GROUP PLC

("K3", the "Company" and including its subsidiaries, the "Group")

 

Investor Presentation

K3 Capital Group plc, a multi-disciplinary professional services firm providing advisory services to SMEs, is pleased to announce that John Rigby, Chief Executive Officer, and Andy Melbourne, Chief Financial Officer, will provide a live presentation relating to the Final results for the year ended 31 May 2021 via the Investor Meet Company platform on 3rd November 2021 at 4:45pm GMT.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet K3 Capital Group plc via:

 

https://www.investormeetcompany.com/k3-capital-group-plc/register-investor

 

Investors who already follow K3 Capital Group plc on the Investor Meet Company platform will automatically be invited.

 

 

For further information, please contact:

K3 Capital Group plc

Tel: c/o finnCap 020 7220 0500

John Rigby, Chief Executive Officer

www.k3capitalgroupplc.com

Andrew Melbourne, Chief Financial Officer

 

 

 

finnCap Ltd (Nominated Adviser and Joint Broker)

Tel: 020 7220 0500

Jonny Franklin-Adams, Charlie Beeson, George Dollemore (Corporate Finance)

Tim Redfern, Richard Chambers (Corporate Broking)

 

 

 

Canaccord Genuity Limited (Joint Broker)

Tel: 020 7523 8000

Bobbie Hilliam (Corporate Broking)

Alex Aylen (Head of Equities)

 

 

 

About K3 Capital

K3 Capital Group plc is a multi-disciplinary professional services firm providing advisory services to SMEs, with operations throughout the UK and overseas.

Services provided by K3 M&A Advisory Group:

Mergers and Acquisitions (M&A) - Company sales, brokerage and corporate finance services to SME's looking to achieve full or partial exit, advising on sales to private, trade, plc, private equity or overseas acquirors. Strategic advisory and valuations, financial due diligence and debt advisory.

Services provided by K3 Tax Advisory Group:

Research & Development tax credit advisory: advising clients on Research and Development Tax Credit (RDTC) claims.

Intax: Tax investigations relating to tax fraud / tax avoidance / disclosures and code of practice 9 (COP9) related work.

 

Services provided by K3 Restructuring Advisory Group:

Restructuring advisory: formal insolvency appointments, informal restructuring advisory, personal insolvency and pension restructuring and insolvency advice.

Financial advisory: comprehensive analysis of business performance through business toolkit, independent reviews, stakeholder management and turnaround and interim support.

Creditor Services: creditor representation and liquidations.

Forensic accounting and expert witness: forensic investigations, intelligence and forensic accounting.

 

The Group's medium-term strategy is to build a wider group of growing and complementary professional services businesses to provide SMEs with high quality advice across specialist disciplines.

K3 Capital Group trades on the London Stock Exchange (AIM: K3C.L), having listed on 11 April 2017. Please visit www.k3capitalgroupplc.com for more information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUWVARAAURAAA
Date   Source Headline
25th Sep 201812:01 pmRNSCompletion of Secondary Placing of Shares
24th Sep 20185:45 pmRNSProposed Secondary Placing of Existing Shares
12th Sep 201812:19 pmRNSNotice of AGM
11th Sep 20187:00 amRNSFinal Results
12th Jun 20187:00 amRNSTrading Update and Notice of Results
5th Jun 20181:15 pmRNSDirector/PDMR Shareholding
30th Apr 20184:30 pmRNSHolding(s) in Company
25th Apr 20182:05 pmRNSSecond Price Monitoring Extn
25th Apr 20182:00 pmRNSPrice Monitoring Extension
3rd Apr 20186:05 pmRNSHolding(s) in Company
9th Mar 20182:15 pmRNSHolding(s) in Company
1st Mar 20187:00 amRNSTrading Statement
17th Jan 20187:00 amRNSGrant of Options
16th Jan 20187:00 amRNSHalf-year Report
11th Dec 20177:00 amRNSTrading Update
29th Nov 20177:00 amRNSDirector/PDMR Shareholding
31st Oct 20177:00 amRNSDirector/PDMR Shareholding
27th Oct 201711:18 amRNSResult of AGM
27th Oct 20177:00 amRNSAGM Statement and Notice of Results
29th Sep 20174:46 pmRNSHolding(s) in Company
28th Sep 20178:45 amRNSCompletion of Secondary Placing of Shares
27th Sep 20175:42 pmRNSProposed Secondary Placing of Shares
20th Sep 20172:21 pmRNSHolding(s) in Company
14th Sep 201712:00 pmRNSNotice of AGM
11th Sep 20177:00 amRNSFinal Results
18th Jul 20177:00 amRNSDirectorate Change
12th Jul 201711:30 amRNSHolding(s) in Company
14th Jun 20177:00 amRNSTrading Statement
31st May 20171:02 pmRNSHolding(s) in Company
22nd May 20177:00 amRNSDirector/PDMR Shareholding
3rd May 20175:30 pmRNSHolding(s) in Company
18th Apr 201710:20 amRNSHolding(s) in Company
18th Apr 201710:15 amRNSHolding(s) in Company
18th Apr 201710:10 amRNSHolding(s) in Company
11th Apr 20177:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.